|
| Fosfomycin susceptible isolates | Fosfomycin resistant isolates | Total susceptibility No (%) | P value | ||
| S No (%) | NS No (%) | S No (%) | NS No (%) | |||
| Cefoperazone-sulbactam | 79(80.6) | 19 (19.4) | 12 (40) | 18 (60) | 76.6 (82) | 0.001 |
| Norfloxacin | 42 (42.9) | 56 (57.1) | 12(40) | 18 (60) | 54 (42.2) | 0.8 |
| Gentanicin | 36 (36.7) | 62 (57.1) | 16 (53.3) | 14 (46.7) | 52 (40.6) | 0.09 |
| Amikacin | 53 (54.1) | 45 (45.9) | 18 (60) | 12 (40) | 71 (55.4) | 0.7 |
| Nitrofurantoin | 40 (40.8) | 58 (59.2) | 10 (33.3) | 20 (66.7) | 50 (39) | 0.5 |
| Trimethoprim- sulphamethoxazole | 19 (19.4) | 79 (80.6) | 9 (30) | 21 (60) | 37 (21.8) | 0.2 |
| Amoxacillin-clavulanic | 26 (26.5) | 72 (73.5) | 13 (43.3) | 17 (56.7) | 39 (30.4) | 0.1 |
| Ampicillin-sulbactam | 25 (25.5) | 73 (74.5) | 6 (20) | 24 (80) | 31 (24.2) | 0.6 |
| Piperacillin-tazobactam | 73 (74.5) | 25 (25.5) | 26 (86.7) | 4 (13.3) | 98 (77.3) | 0.2 |
| Imipenem | 96 (98) | 2 (2) | 25 (83.3) | 5 (16.7) | 121 (94.5) | 0.008 |